Home  |  About JAPTR |  Editorial board  |  Search |  Ahead of print  |  Current issue  |  Archives |  Submit article  |  Instructions  |  Subscribe  |  Advertise  |  Contacts  |Login 
Users Online: 359   Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
     
This article has been cited by
1Neuromodulatory effects of anti-diabetes medications: A mechanistic review
Habib Yaribeygi,Milad Ashrafizadeh,Neil C. Henney,Thozhukat Sathyapalan,Tannaz Jamialahmadi,Amirhossein Sahebkar
Pharmacological Research.2020;152()104611
[DOI]
2Takotsubo cardiomyopathy: an obscure cause of emerging cardiovascular manifestations in the setting of Bickerstaff’s brainstem encephalitis
Kenan Yalta,Ertan Yetkin,Tulin Yalta
Neurological Sciences.2021;42(3)1181
[DOI]
3WITHDRAWN: Common NLRP3 inflammasome inhibitors and Covid-19: Divide and Conquer
Gaber El-Saber Batiha,Dr. Ali I. Al-Gareeb,Safaa Qusti,Eida M. Alshammari,Damilare Rotimi,Oluyomi Stephen Adeyemi,Hayder M. Al-kuraishy
Scientific African.2021;42(3)e01084
[DOI]
4Effects of linagliptin vs glimepiride on cognitive performance in type 2 diabetes: results of the randomised double-blind, active-controlled CAROLINA-COGNITION study
Geert Jan Biessels,Chloë Verhagen,Jolien Janssen,Esther van den Berg,Gudrun Wallenstein,Bernard Zinman,Mark A. Espeland,Odd Erik Johansen
Diabetologia.2021;64(6)1235
[DOI]
5Cardiac myxoma as a potential trigger of takotsubo cardiomyopathy: A brief review on mechanistic and clinical perspectives
Kenan Yalta,Ugur Ozkan,Tülin Yalta,Ertan Yetkin
Monaldi Archives for Chest Disease.2021;64(6)1235
[DOI]
6Glimepiride mitigates tauopathy and neuroinflammation in P301S transgenic mice: role of AKT/GSK3ß signaling
Mennatallah O. Zaki,S. El-Desouky,Doaa A. Elsherbiny,Mohamed Salama,Samar S. Azab
Inflammopharmacology.2022;30(5)1871
[DOI]
7The clinical aspects ot the sulphonylurea compounds from the position of the cardioprotective approach at patient with type 2 diabetes, using glucocardiomonitoring
N. A. Chernikova,L. L. Kamynina,A. S. ?metov,D. A. Sychov
Diabetes mellitus.2022;25(4)378
[DOI]
8Neuroprotective Effects of Diabetes Drugs for the Treatment of Neonatal Hypoxia-Ischemia Encephalopathy
Laura Poupon-Bejuit,Eridan Rocha-Ferreira,Claire Thornton,Henrik Hagberg,Ahad A. Rahim
Frontiers in Cellular Neuroscience.2020;14(4)378
[DOI]
9Common NLRP3 inflammasome inhibitors and Covid-19: Divide and conquer
Gaber El-Saber Batiha,Ali I. Al-Gareeb,Damilare Rotimi,Oluyomi Stephen Adeyemi,Hayder M. Al-kuraishy
Scientific African.2022;18(4)e01407
[DOI]
10COVID-19 in Relation to Hyperglycemia and Diabetes Mellitus
Hayder M. Al-kuraishy,Ali I. Al-Gareeb,M. Alblihed,Susana G. Guerreiro,Natália Cruz-Martins,Gaber El-Saber Batiha
Frontiers in Cardiovascular Medicine.2021;8(4)e01407
[DOI]
11Current Therapies for Neonatal Hypoxic–Ischaemic and Infection-Sensitised Hypoxic–Ischaemic Brain Damage
Konstantina Tetorou,Claudia Sisa,Arzo Iqbal,Kim Dhillon,Mariya Hristova
Frontiers in Synaptic Neuroscience.2021;13(4)e01407
[DOI]
12Targeting of neuroinflammation by glibenclamide in Covid-19: old weapon from arsenal
Gaber El-Saber Batiha,Hayder M. Al-kuraishy,Ali I. Al-Gareeb,Mubarak Alruwaili,Raed AlRuwaili,Sarah M. Albogami,Mohammed Alorabi,Hebatallah M. Saad,Jesus Simal-Gandara
Inflammopharmacology.2022;13(4)e01407
[DOI]
  Feedback 
  Subscribe 




Most popular articles
Join us as a reviewer
Email alerts
Recommend this journal